© 2020 MJH Life Sciences and Drug Topics. All rights reserved.
July 17, 2019
First oral drug for advanced or metastatic bladder cancer.
June 13, 2019
Both responder and remitter patients experienced a statistically significant longer time to relapse with esketamine compared to the placebo
April 04, 2018
FDA approves apalutamide for castration-resistant prostate cancer.
January 04, 2018
Emicizumab-kxwh brings together factors IXa and X to restore the function of the missing activated factor VIII and the blood clotting process.